Oct 7, 2016
Sloan Alum Startup twoXAR Uses Big Data to Connect Diseases with Drugs
MIT Sloan School of Management recently published an article on biopharmaceutical firm twoXAR (pronounced “two czar”), launched by Sloan alumnus Andrew M. Radin (MBA ‘14) and Andrew A. Radin (no relation). The firm takes a big data approach to scan “the handful of drug candidates out of a drug library of thousands, if not millions, that would most effectively treat a specific disease.”
Continue reading…